Yanyan Geng

Title: Yanyan Geng: Innovator in Neuropilin-2 Research

Introduction

Yanyan Geng is a notable inventor based in San Diego, CA, who has made significant contributions to the field of biomedical research. He holds two patents that focus on innovative compositions and methods involving anti-NRP2 antibodies. His work aims to advance therapeutic approaches for diseases associated with neuropilin-2.

Latest Patents

Yanyan Geng's latest patents include compositions and methods comprising anti-NRP2 antibodies. These patents provide antibodies and antigen-binding fragments that specifically bind to human neuropilin-2 (NRP2) polypeptides. The inventions include methods that modulate binding interactions between human NRP2 and at least one NRP2 ligand, such as human histidyl-tRNA synthetase (HRS). This modulation can influence downstream signaling events mediated by NRP2, leading to potential therapeutic applications for treating NRP2-associated diseases.

Career Highlights

Yanyan Geng is currently employed at Atyr Pharma, Inc., where he continues to develop innovative solutions in the realm of therapeutic antibodies. His research is pivotal in understanding the role of NRP2 in various diseases, and his patents reflect his commitment to advancing medical science.

Collaborations

Yanyan collaborates with talented individuals such as Luke Burman and Yee Ting (Esther) Chong, who contribute to the innovative environment at Atyr Pharma, Inc. Their combined expertise fosters a dynamic research atmosphere that enhances the development of new therapeutic strategies.

Conclusion

Yanyan Geng's work in the field of neuropilin-2 research exemplifies the impact of innovative thinking in biomedical science. His patents and collaborations highlight the importance of teamwork in advancing healthcare solutions.